Clock Genes Regulate Ca 2+ Signaling and Mitochondrial Bioenergetics to Inhibit Sjögren Disease

Documenti analoghi

• Living With Sjögren Disease: Prospects for Disease‐Modifying Therapies
  di: E. William St. Clair
  Pubblicazione: (2024)
• Serum and Tissue Biomarkers Associated With Composite of Relevant Endpoints for Sjögren Syndrome (CRESS) and Sjögren Tool for Assessing Response (STAR) to B Cell–Targeted Therapy in the Trial of Anti–B Cell Therapy in Patients With Primary Sjögren Syndrome (TRACTISS)
  di: Elena Pontarini, et al.
  Pubblicazione: (2024)
• Iguratimod alleviated Sjögren's syndrome through regulating macrophage polarization
  di: Junqiao Guo, et al.
  Pubblicazione: (2025)
• Successful treatment with upadacitinib for Sjögren's syndrome complicated by atopic dermatitis
  di: Haojie Xu, et al.
  Pubblicazione: (2024)
• Associations of aged neutrophils with disease activity in primary Sjögren's syndrome
  di: Lei Han, et al.
  Pubblicazione: (2025)